Table 3 Socio-demographic description of the schizophrenia group and the healthy control group.

From: Using mimicry of body movements by a virtual agent to increase synchronization behavior and rapport in individuals with schizophrenia

 

Schizophrenia Patients (N = 19)

Healthy Controls (N = 19)

Statistics

M

SD

Med

Rg

M

SD

Med

Rg

Age

31.9

9.4

30

22–59

30.5

8.4

27

21–47

U = 143.5

z = −0.30

p = 0.77

Level of Education

13.0

2.6

13

9–17

13.7

2.2

14

9–17

U = 143.5

z = 1.07

p = 0.28

fNART

25.1

6.1

27

13–33

27.8

4.3

29

18–34

U = 135.5

z = 1.30

p = 0.19

PANSS Positive

12.5

4.2

14

7–19

       

PANSS Negative

13.1

3.8

13

8–20

       

PANSS General Psychopathology

24.5

6.2

23

17–41

       

PANSS Total score

50.1

10.4

51

34–76

       

PANSS-5-POSITIVE

13.1

5.8

14

5–25

       

PANSS-5-NEGATIVE

13.4

4.5

13

6–21

       

PANSS-5-DISORGANIZATION

13.3

2.8

12

10–20

       

PANSS-5-EXCITMENT

11.2

2.3

11

8–16

       

PANSS-5-EMOTIONAL DISTRESS

16.0

5.9

16

8–27

       

CPZ equivalent dose in mg

473.89

346.26

310

100–1500

       

Illness Duration

9.06

7.3

6.5

2–31

       
 

N

%

  

N

%

     

Gender/Man

16

84

  

17

89

  

χ2 (1, N = 38) = 0.23

p = 0.63

 
  1. Mean, Standard deviation, Median and Range of values are presented for the Age, Gender, Level of education, general and sub dimensions of the PANSS, Illness duration and Chlorpromazine equivalent dose. Group statistics are presented using appropriates non-parametric tests.
Back to article page